GLP-1 users reshape nutrition product development, say ADM, Cargill & Synergy Flavours
The use of GLP-1 medications for weight loss continues to rise. The Gallup National Health and Well-Being Index estimates that 11% of US adults took these medications for weight loss in 2026, compared to 3% in 2024. Experts from ADM, Synergy Flavours, and Cargill tell Nutrition Insight how the growing use of these medications changes the nutrition industry’s approach to product development. They also point to nutritional challenges for people using these drugs, key formulation considerations, and their expectations surrounding the evolving GLP-1 companion nutrition market.HMOs and precision proteins push infant formula closer to breast milk
The nutrition industry is innovating in solutions for one of its most vulnerable consumer groups, infants. Nutrition Insight sits down with experts from Novonesis, Valio, Arla Foods Ingredients, and Lubrizol to discuss how the industry is shifting toward creating products as similar as possible to the “gold standard of infant nutrition” — human breast milk. We also discuss how external factors, such as recent infant formula withdrawals, have shaped the industry. Joey Zhu, global commercial development manager for Early Life and Specialized Nutrition at Novonesis Human Health, spots the main trend in infant nutrition innovation, which is making formula more closely reflect the composition and benefits of breast milk, while being supported by robust scientific evidence.Uncover the next frontier in digestive health innovation: histamine intolerance
The most overlooked opportunity in digestive health right now? Histamine intolerance.Consumer interest is building, but solutions are still relatively underdeveloped. What’s driving the shift – and why could enzymes be part of what comes next? Explore the trends, science and untapped potential around histamine intolerance in our latest guide.
Technical paper brought to you by Bioiberica.
Pure love deserves a pure start: Solutions that give the best start from day one
Join us to explore how the latest DHA guidelines can inform product innovation. We’ll cover the recommended intake levels, highlight the gap between recommendations and current prenatal formulations, and discuss the barriers that prevent women from staying on their supplements. These include pill burden and digestive discomfort, which lead nearly 30% of women to discontinue use. We'll conclude by showcasing how life'sDHA® gummies, Smart Chews, and capsules help overcome these challenges with high-dose DHA in formats women prefer and stay with.CPHI Milan 2026 recap: Nutrition suppliers see affordability squeeze alongside metabolic health boom
At CPHI Milan 2026, AB Biotics, Fermenta Biotech, Ingredia, Probiotical, and Select Botanical told us what buyers asked of them this year. Affordability is shaping the macro picture, while metabolic health and inflammation drive trends. Women’s health and hormone balance dominated while pharmaceutical interest in probiotics grew. They pointed to healthy longevity and holistic health approaches as the next wave of innovation.CPHI Milan 2026 review: Pharma standards raise the bar for nutraceuticals
At CPHI Milan 2026 in Italy (Oct 6–8), suppliers said nutraceutical ingredients are increasingly meeting pharmaceutical standards. Companies told Nutrition Insight that pharma interest in biotics is growing, while clinical evidence helps nutraceutical firms enter the medical sector. Exhibitors featured natural extracts, enzymes, vitamins, minerals, proteins, fiber, and lipids, along with innovations in delivery formats. Metabolic health continues to dominate trends, women’s health is growing rapidly, and sustainability concerns are shaping supply chains. Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position

Latest headlines
View more
Highlighted features

GLP-1 companion ingredients Oct 2026
Multimedia
View more
CPHI Milan 2026 recap: Nutrition suppliers see affordability squeeze alongside metabolic health boom
At CPHI Milan 2026, AB Biotics, Fermenta Biotech, Ingredia, Probiotical, and Select Botanical told us what buyers asked of them this year. Affordability is shaping the macro picture, while metabolic health and inflammation drive trends. Women’s health and hormone balance dominated while...
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement




































